Interaction between Cardioverter Defibrillator and Enhanced External Counterpulsation Device

Basit Öğe Kaydı
dc.contributor.authorCelik, Omer
dc.contributor.authorAydin, Alper
dc.contributor.authorYilmazer, Mustafa S.
dc.contributor.authorSarigul, Nedim U.
dc.contributor.authorGurol, Tayfun
dc.contributor.authorDagdeviren, Bahadir
dc.date.accessioned2024-07-12T21:52:40Z
dc.date.available2024-07-12T21:52:40Z
dc.date.issued2013en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractBackground Potential interference between implanted cardiac devices and other medical instruments is an important concern. Therefore, we aimed to investigate the possible device interaction between implantable cardioverter defibrillators (ICDs) and external enhanced counterpulsation (EECP) treatment. Methods Twenty-one patients with an implanted ICD or cardiac resynchronization therapy with defibrillator (CRT-D) were enrolled into the study. EECP had applied as two sessions of 5 minutes. Data from device interrogations before and after the first EECP session and during second EECP session were recorded and analyzed for signs of possible device interaction. Results There was no sign of inappropriate sensing or noise during EECP session. There was no difference regarding electrode impedance, pacing, and sensing values before and after EECP. There was a statistically significant difference regarding heart rates during EECP therapy between rate response off and on modes (68.69 +/- 5.92 beats/min and 90.32 +/- 11.05 beats/min, respectively P = 0,001). In four patients with CRT-D and unipolar left ventricular pacing, counterpulsation could not be done because of QRS sensing problems. Conclusions EECP seems to be a safe treatment modality in patients with implanted ICD and CRT-D devices. It should be kept in mind that in those patients with CRT-D, rate responsive mode is on; inappropriate sinus tachycardia can be seen during EECP therapy. Also in patients with CRT-D using a unipolar sensing mode, problems of QRS complex sensing by the EECP may occur and, therefore, this effects synchronization and success of EECP therapy.en_US
dc.identifier.doi10.1111/pace.12178
dc.identifier.endpage1106en_US
dc.identifier.issn0147-8389
dc.identifier.issue9en_US
dc.identifier.pmid23713720en_US
dc.identifier.scopus2-s2.0-84883487698en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1104en_US
dc.identifier.urihttps://dx.doi.org/10.1111/pace.12178
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8417
dc.identifier.volume36en_US
dc.identifier.wosWOS:000323824400008en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWILEY-BLACKWELLen_US
dc.relation.ispartofPACE-PACING AND CLINICAL ELECTROPHYSIOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY03197
dc.subjectimplantable cardioverter defibrillatoren_US
dc.subjectenhanced external counterpulsationen_US
dc.subjectheart failureen_US
dc.subjectEECPen_US
dc.titleInteraction between Cardioverter Defibrillator and Enhanced External Counterpulsation Deviceen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu